MX2010012836A - Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos. - Google Patents

Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos.

Info

Publication number
MX2010012836A
MX2010012836A MX2010012836A MX2010012836A MX2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A MX 2010012836 A MX2010012836 A MX 2010012836A
Authority
MX
Mexico
Prior art keywords
compounds
inflammatory
methods
pharmaceutical formulations
steroidal anti
Prior art date
Application number
MX2010012836A
Other languages
English (en)
Spanish (es)
Inventor
Peter C Hoyle
Paul Waymack
Original Assignee
Kitov Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitov Pharmaceutical Ltd filed Critical Kitov Pharmaceutical Ltd
Publication of MX2010012836A publication Critical patent/MX2010012836A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX2010012836A 2008-05-28 2009-05-22 Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos. MX2010012836A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5678908P 2008-05-28 2008-05-28
US9797208P 2008-09-18 2008-09-18
PCT/US2009/044966 WO2009154944A2 (en) 2008-05-28 2009-05-22 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds

Publications (1)

Publication Number Publication Date
MX2010012836A true MX2010012836A (es) 2011-09-27

Family

ID=41434626

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010012836A MX2010012836A (es) 2008-05-28 2009-05-22 Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos.

Country Status (7)

Country Link
US (2) US20110207724A1 (https=)
EP (1) EP2285371A4 (https=)
JP (1) JP2011525479A (https=)
AU (1) AU2009260632A1 (https=)
CA (1) CA2726337A1 (https=)
MX (1) MX2010012836A (https=)
WO (1) WO2009154944A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015191460A1 (en) * 2014-06-08 2015-12-17 Autotelic Llc Fixed dose combination for pain relief without edema
WO2019067768A2 (en) * 2017-09-28 2019-04-04 Nevakar, Inc. FIXED DOSE COMBINATION FORMULATIONS FOR THE TREATMENT OF PAIN
WO2020091711A1 (en) * 2018-11-01 2020-05-07 Pisak Mehmet Nevzat Pharmaceutical combinations for the treatment of pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155120A (en) * 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
US20040186155A1 (en) * 2003-01-30 2004-09-23 Dayno Jeffrey Marc Combination therapy for the treatment or prevention of migraine
WO2006102476A2 (en) * 2005-03-21 2006-09-28 Vicus Therapeutics Spe 1, Llc Compositions and methods for ameliorating cachexia
US20070037797A1 (en) * 2005-08-15 2007-02-15 Hellstrom Harold R Method of reducing the risk of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which favor CV events

Also Published As

Publication number Publication date
EP2285371A4 (en) 2012-01-25
US20110207724A1 (en) 2011-08-25
US20160243134A1 (en) 2016-08-25
AU2009260632A1 (en) 2009-12-23
CA2726337A1 (en) 2009-12-23
EP2285371A2 (en) 2011-02-23
WO2009154944A3 (en) 2010-04-01
JP2011525479A (ja) 2011-09-22
WO2009154944A2 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
IL194885A0 (en) Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
IL196425A (en) Oral unit dose form containing ibuprofen and famotidine
ATE486593T1 (de) Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
NZ602029A (en) Use of meloxicam for the long-term treatment of kidney disorders in cats
EA200901237A1 (ru) Применение димирацетама при лечении хронической боли
MX2010012836A (es) Formulaciones farmaceuticas y metodos de uso que combinan compuestos antiinflamatorios no esteroides con compuestos antihipertensivos.
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
HN2011000661A (es) Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual
JP2011525479A5 (https=)
RU2019102890A (ru) Фармацевтические композиции, содержащие флурбипрофен
WO2019067768A4 (en) Fixed dose combination formulations for treating pain
AR081007A1 (es) Combinacion farmaceutica caracterizada porque comprende ibuprofeno y l-arginina
AR055807A1 (es) Composicion farmaceutica sinergistica de diclofenaco y clonixinato de lisina
WO2013100881A3 (en) Combined pharmaceutical formulation containing diacerein
EA201000810A1 (ru) Фармацевтическая композиция
AR060205A1 (es) Composicion farmaceutica sinergistica de carisoprodol y clonixinato de lisina
MX395289B (es) Efecto analgesico local de la combinacion del acido docosahexaenoico dha y naproxeno.
AR075414A1 (es) Composiciones y metodos para terapia extendida con aminopiridinas
WO2006081088A3 (en) Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid
EA201200238A1 (ru) Комбинированная противотуберкулезная композиция
HK1214529A1 (zh) 膽汁酸螯合劑的胃滯留緩釋口服劑型